SCHEMBL7019094

SCHEMBL7019094

COc1ccc(CCCCOc2ccc(CSc3c(Cl)cccc3Cl)nc2/C=C/C(=O)O)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LTB4R Q15722 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7019099 1.00 LTB4R (1.00) LTB4R
SCHEMBL7022316 0.99 LTB4R (0.98) LTB4R
SCHEMBL7022308 0.99 LTB4R (0.98) LTB4R
SCHEMBL7020679 0.95 LTB4R (1.00) LTB4R
SCHEMBL7020686 0.95 LTB4R (1.00) LTB4R
SCHEMBL9114192 0.92 LTB4R (0.86) LTB4R
SCHEMBL9114186 0.92 LTB4R (0.86) LTB4R
Lithium Ion SCHEMBL7025236 0.92 LTB4R (0.85) LTB4R
SCHEMBL8080580 0.91 LTB4R (0.84) LTB4R
SCHEMBL8080575 0.91 LTB4R (0.84) LTB4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0649412-B1 PHARMACEUTICAL PYRIDINE COMPOUNDS SMITHKLINE BEECHAM CORP (US) 2003-01-15 EP claimed
US-5643914-A Pharmaceutical pyridine compounds SMITHKLINE BEECHAM CORPORATION (US) 1997-07-01 US claimed
EP-0649412-B1 PHARMACEUTICAL PYRIDINE COMPOUNDS SMITHKLINE BEECHAM CORP (US) 2003-01-15 EP disclosed
EP-0812194-B1 Use of substituted pyridine compounds for treating atopic dermatitis and contact dermatitis SMITHKLINE BEECHAM CORP (US) 2000-08-16 EP disclosed
US-5990314-A LEUKOTRIENE ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1999-11-23 US disclosed
US-5643914-A Pharmaceutical pyridine compounds SMITHKLINE BEECHAM CORPORATION (US) 1997-07-01 US disclosed
EP-0733044-A4 COMPOUNDS SMITHKLINE BEECHAM CORP (US) 1997-03-05 EP disclosed
EP-0733044-A1 COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1996-09-25 EP disclosed
EP-0649412-A4 PHARMACEUTICAL PYRIDINE COMPOUNDS. SMITHKLINE BEECHAM CORP (US) 1995-07-05 EP disclosed
EP-0649408-A4 PROCESS FOR MAKING PHENYLTHIOMETHYLPYRIDINYLALKENOATES. SMITHKLINE BEECHAM CORP (US) 1995-06-21 EP disclosed
WO-1995015950-A1 COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1995-06-15 WO disclosed
EP-0649412-A1 PHARMACEUTICAL PYRIDINE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1995-04-26 EP disclosed
EP-0649408-A1 PROCESS FOR MAKING PHENYLTHIOMETHYLPYRIDINYLALKENOATES SMITHKLINE BEECHAM CORPORATION (US) 1995-04-26 EP disclosed
WO-1994000433-A1 PROCESS FOR MAKING PHENYLTHIOMETHYLPYRIDINYLALKENOATES SMITHKLINE BEECHAM CORPORATION (US) 1994-01-06 WO disclosed
WO-1994000437-A1 PHARMACEUTICAL PYRIDINE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1994-01-06 WO disclosed